Gas6 and Soluble MerTK in Periodontal Diseases
Evaluation of Gas6 and Soluble MerTK Levels in Gingival Crevice Fluid in Individuals With Periodontal Health, Gingivitis, and Periodontitis
1 other identifier
observational
90
1 country
1
Brief Summary
This study aimed to investigate gingival crevicular fluid (GCF) and serum soluble MerTK (sMerTK) and Gas6 levels in periodontal health and disease. A total of 90 individuals, 30 patients with stage III grade B periodontitis, 30 with gingivitis and 30 periodontally healthy individuals were included. Whole-mouth and site-specific clinical periodontal parameters including probing depth, clinical attachment level, bleeding on probing, gingival index, plaque index were recorded. GCF and serum sMerTK and Gas6 levels were measured by enzyme-linked immunosorbent assay. Statistical analysis was performed by using non-parametric tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 25, 2026
CompletedFirst Submitted
Initial submission to the registry
April 2, 2026
CompletedFirst Posted
Study publicly available on registry
April 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 20, 2026
April 16, 2026
April 1, 2026
2 months
April 2, 2026
April 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Gas6 Levels in Gingival Crevicular Fluid
Quantitative measurement of Gas6 levels (pg/mL) in gingival crevicular fluid samples using enzyme-linked immunosorbent assay (ELISA), and comparison of these levels among periodontally healthy, gingivitis, and periodontitis groups.
baseline
Soluble MerTK (sMerTK) Levels in Gingival Crevicular Fluid
Quantitative measurement of soluble MerTK (sMerTK) levels (pg/mL) in gingival crevicular fluid samples using enzyme-linked immunosorbent assay (ELISA), and comparison of these levels among periodontally healthy, gingivitis, and periodontitis groups.
baseline
Secondary Outcomes (4)
Plaque Index
baseline
Probing Depth
baseline
Clinical Attachment Loss
baseline
Gingival Index
baseline
Study Arms (3)
periodontally healthy (H) group
gingivitis (G) group
stage III grade B periodontitis (P) group
Interventions
Gingival crevicular fluid collection using sterile paper strips inserted into the gingival sulcus for 30 seconds from selected periodontal sites (healthy, gingivitis, and periodontitis) for biomarker analysis (Gas6 and sMerTK).
Eligibility Criteria
This clinical study will be conducted on individuals who apply to the Department of Periodontology, Faculty of Dentistry, Abant İzzet Baysal University.
You may qualify if:
- Individuals without systemic diseases that may affect periodontal tissues (such as cardiovascular diseases, atherosclerosis, immune system disorders, rheumatoid arthritis, obesity, cancer, and diabetes)
- Individuals who have not used antibiotics within the last 3 months
- Individuals not taking any medications known to affect periodontal tissues
- Individuals without infectious diseases such as HIV, hepatitis B virus (HBV), or tuberculosis
- Individuals with at least 16 natural teeth, excluding third molars
- Individuals aged 18 years and older
You may not qualify if:
- Pregnant or lactating individuals
- Individuals who have received periodontal treatment within the last 6 months
- Current smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bolu Abant Izzet Baysal University Faculty of Dentistry
Bolu, Bolu, 14030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 2, 2026
First Posted
April 16, 2026
Study Start
March 25, 2026
Primary Completion (Estimated)
May 10, 2026
Study Completion (Estimated)
May 20, 2026
Last Updated
April 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share